http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2972328-A2
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_94ff2d78578d95d1e8d3a2233c76188d |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6881 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-5091 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-50 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-68 |
| filingDate | 2014-03-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e347ef19f2906020c5ead526a277fb1e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_921d6ac2f365679f18db6099a5de16a8 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f2d216fafa90b52acfa5bdd72bc2fa2c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_02c7c9dda9db7ea93a4ba3b1511e3831 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_94e5e999217d285e3c243ffde0afe853 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_42349f4295cf02b037e8e2bd8fef69a2 |
| publicationDate | 2016-01-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | EP-2972328-A2 |
| titleOfInvention | A noninvasive method for measuring antimicrobial peptides from skin as an objective measurement of natural protection from microbes |
| abstract | A noninvasive method for measuring skin health in a subject comprising collecting an epithelial cell /skin cell sample from the subject; detecting a level of one or more antimicrobial peptide biomarkers in the epithelial cell sample/skin cell sample; diagnosing the subject as having a defense mechanism due to microbial attack on skin or a measure of the system being in balance with environment homeostasis based on the level of one or more antimicrobial peptide biomarkers selected from the group consisting of Histone H2B type 1-M, Histone H2A, Histone H4, Protein S100-A7, Protein S100-A8, Protein S100-A9, Cathepsin G, Neutrophil defensin 3 (Defensin, alpha 3) (HNP-3), Dermcidin, Ribonuclease 7 (RNase 7), human beta-defensin -2 (nBD-2) and Beta-defensin 103 (hBD-3) and listed in Table 1 wherein the AMP families include bactericidal permeability-increasing protein (BPI), Defensin, Histone, Pore-forming toxin, S100 protein, Cytotoxin, Serine Protease S1, Dual Oxidase, transcription regulation, and mixtures thereof. Further, a noninvasive method for evaluating the efficacy of products for skin health. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3287782-A1 |
| priorityDate | 2013-03-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 412.